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ABSTRACT
Abasic sites (AP-sites) are frequent DNA lesions,
arising by spontaneous base hydrolysis or as inter-
mediates of base excision repair (BER). The hemiac-
etal at the anomeric centre renders them chemically
reactive, which presents a challenge to biochemical
and structural investigation. Chemically more stable
AP-site analogues have been used to avoid sponta-
neous decay, but these do not fully recapitulate the
features of natural AP-sites. With its 3′-phosphate
replaced by methylene, the abasic site analogue
3CAPS was suggested to circumvent some of these
limitations. Here, we evaluated the properties of
3CAPS in biochemical BER assays with mammalian
proteins. 3CAPS-containing DNA substrates were
processed by APE1, albeit with comparably poor ef-
ficiency. APE1-cleaved 3CAPS can be extended by
DNA polymerase  but repaired only by strand dis-
placement as the 5′-deoxyribophosphate (dRP) can-
not be removed. DNA glycosylases physically and
functionally interact with 3CAPS substrates, under-
lining its structural integrity and biochemical reactiv-
ity. The AP lyase activity of bifunctional DNA glycosy-
lases (NTH1, NEIL1, FPG), however, was fully inhib-
ited. Notably, 3CAPS-containing DNA also effectively
inhibited the activity of bifunctional glycosylases on
authentic substrates. Hence, the chemically stable
3CAPS with its preserved hemiacetal functionality is
a potent tool for BER research and a potential in-
hibitor of bifunctional DNA glycosylases.
INTRODUCTION
DNA – the carrier of the genetic information – is intrinsi-
cally an unstable molecule (1). In cells, physical and chem-
ical agents of endogenous and environmental origin con-
tinuously cause damage to the chemical structure of DNA,
which needs to be fixed by DNA repair mechanisms to
avoid excessive mutagenesis and cellular toxicity. Among
the many forms of DNA damage, base hydrolysis and sim-
ple base modifications represent the majority of sponta-
neously occurring lesions. DNA base damage is mainly
recognised and repaired by the base excision repair (BER)
system (2,3,4). Besides the repair of canonical DNA base
lesions, BER has also been linked to the regulation of gene
expression, the control of DNA methylation as well as so-
matic hypermutation and class switch recombination in ac-
tivated B cells (5,6).
Abasic sites (AP-sites) occur with high frequency as a
result of spontaneous hydrolysis of the N-glycosidic bond
connecting the base with the deoxyribose moiety of the nu-
cleotide but also as an intermediate of BER, following the
excision of damaged DNA bases by monofunctional DNA
glycosylases. Under physiological conditions, AP-sites ex-
ist mainly as hemiacetals at the anomeric centre with ap-
proximately 1% forming ring-opened or hydrated aldehydes
that are chemically reactive (7). These can undergo sponta-
neous β- and δ-elimination, which causes the DNA strand
to break 5′ and 3′ of the lesion, generating single nucleotide
gaps with 3′- and 5′-phosphate termini. This chemical de-
cay of AP-sites represents a challenge for the cellular DNA
repair system but also interferes with the biochemical in-
vestigation of BER processes in vitro. To avoid substrate in-
homogeneity in biochemical and structural studies, a range
of chemically stable AP-site analogues for both the open-
chain and ring-closed form have been synthesised and ap-
plied. Their chemical modifications change key structural
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Figure 1. The 3CAPS AP-site analogue is chemically stable in physiolog-
ical buffers. (A) Chemical structures of the natural AP-site (AP) and the
analogues 3CAPS (12) and tetrahydrofuran (THF) (9), included in the syn-
thetic repair substrates with a 5′-fluorescein label (F). (B) DNA substrates
containing either G•U mismatches (MM), enzymatically produced AP-
sites or 3CAPSwere incubated in a physiological buffer supplementedwith
130 g/ml protein (BSA) at 37◦C. The spontaneous degradation of DNA
substrates was assessed over time, indicated by faster migrating product
bands on denaturing gel electrophoresis. Lane C+ shows the degradation
of substrates induced by heating to 99◦C in alkaline conditions for 10 min.
(C) Quantitative analysis of the chemical stability of the various substrates.
Error bars, standard errors of the mean (SEM) of three experiments.
and functional features at the anomeric centre, which may
be critical for its biological activity – hence, these modifi-
cations may not recapitulate the biologically relevant func-
tionalities of natural AP-sites.
The tetrahydrofuran (THF) and the pyrrolidino analogue
are the chemically modified AP-sites most commonly used
for research purposes (8,9). Both of them lack the hemiac-
etal functionality and thus the anomeric centre at position
C1´ (Figure 1A), which is essential for the catalytic mecha-
nisms of bifunctional DNA glycosylases/AP lyases. These
enzymes form a Schiff base intermediate with the AP-site
in the incision reaction (10). In addition, the hemiacetal is
proposed to stabilise and optimise the orientation of the
AP-site in the active-site pocket of the major mammalian
AP-endonucleases APE1 (11). By contrast, another more
recently introduced AP-site analogue, 3CAPS (3′-carbon
AP-site), combines the full natural functionality with com-
plete stability at the 3′-centre, even under alkaline condi-
tions (12). This was achieved by the conversion of the 3′-
oxygen of an AP-site into a methylene unit (Figure 1A).
The resulting phosphonate in the DNA backbone is sug-
gested to be iso-structural to the natural phosphodiester
and maintains the charge of the 3′-phosphate but renders it
chemically less reactive and thereby more stable. Since the
modification is restricted to the 3′ position, an endonucle-
olytic attack 5′ of the lesion is expected to still be possible.
On the other hand, enzymes that process AP-sites via a β-
elimination are expected to halt at this step. This predicts
that AP-endonucleases (e.g. APE1) are able to incise 5′ of
the 3CAPS but the β-lyase activity of DNA polymerase 
(Pol) or bifunctional DNA glycosylases will not be able to
react and, hence, to produce a sealable DNA end. Such a
substrate would strictly require repair by long-patch BER,
involving strand displacement and endonucleolytic removal
of the resulting 5′-flap structure.
In this study, we addressed these predictions by test-
ing the functionality and processing of the AP-site ana-
logue 3CAPS in in vitro reconstituted BER reactions. In
comparison with natural AP-sites and THF analogues,
we investigated kinetic parameters of 3CAPS processing
by APE1 to confirm the hydrolytic cleavage 5′ to the le-
sion. To test their structural authenticity, we examined
the interaction of 3CAPS-containing DNA substrates with
known AP-site binding DNA glycosylases. Moreover, we
investigated the potential of 3CAPS to block BER involv-
ing β-elimination in the context of a possible application
as inhibitor/competitor of such enzymes. Finally, we ex-
plored the behaviour of the 3CAPS substrate downstream
of DNA strand incision with regard to repair synthesis and
BER sub-pathway choice. Our experimental data provide
a proof-of-concept for the suitability of 3CAPS as tool for
functional investigation of BER in vitro and in vivo and re-
veal properties implicating a potential as an inhibitor of
short-patch BER.
MATERIALS AND METHODS
Recombinant proteins
Escherichia coli FPG; Endo IV and UDG were purchased
from NEB (Ipswich, MA, USA), T4 polynucleotide kinase
from Thermo-Fisher Scientific (Waltham, MA, USA). Hu-
man NTH1 and NEIL1 were purified as previously de-
scribed (13). Human BER proteins (APE1, TDG, XRCC1,
LIG3 and Pol) were expressed in E.coli BL21(De3) cells
grown in 2YTmediumand purified using the A¨kta Explorer
10 (GE Healthcare) HPLC system. Standard buffers and
protocols for Ni-NTA (HisTrap HP; 50 mMNa-phosphate
pH 7.5, 500 mM NaCl, 10% glycerol, 2.5–250 mM im-
idazole, 0.1% Tween-20, 10 mM -mercaptoethanol, 1%
PMSF) and Heparin (HiTrap Heparin HP; 25 mM Na-
phosphate pH 7, 0.02–1.5 M NaCl, 5% glycerol, 10 mM
 at U
niversitÃ¤t Bern Volkswirtschftliches Institut on February 3, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 3
-mercaptoethanol, 0.1% PMSF) affinity purification were
applied if not stated otherwise. In brief, cDNAs encod-
ing C-terminally 6His-tagged APE1 (gi: 18375501) and
XRCC1 (gi: 190684675) or N-terminally 6His-tagged TDG
(gi: 59853162) were expressed from pET28c(+)-derived vec-
tors (Novagen/Merck Millipore, Billerica, MA, USA). N-
terminally 6His-tagged Pol (gi: 4505931) was expressed
from pQE30 (QIAGEN, Hombrechtikon, Switzerland).
Plasmid DNA and sequences are available from Addgene
(ID 70757–70761; http://www.addgene.org). APE1 was ex-
pressed with 500 M IPTG at 25◦C for 6 h and puri-
fied by Ni-NTA affinity and cation exchange chromatogra-
phy (RESOURCE S; 25 mM Na-phosphate pH 6.9, 0.05–
1 M NaCl, 5% glycerol, 5 mM -mercaptoethanol, 0.1%
PMSF). XRCC1 was expressed with 250 M IPTG at 25◦C
for 4 h and purified by Ni-NTA and Heparin affinity fol-
lowed by anion exchange chromatography (RESOURCE
Q; 50 mM Bicine-NaOH pH 8.8, 0.025–1 M NaCl, 20%
glycerol, 5 mM -mercaptoethanol, 0.1% PMSF). Pol was
expressed with 250 M IPTG at 25◦C for 3.5 h and pu-
rified as APE1. TDG was expressed with 250 M IPTG
at 15◦C for 22 h and purified with Ni-NTA and Heparin
affinity followed by anion exchange chromatography (RE-
SOURCE Q; 20 mM Tris-HCl pH 8.5, 0.005–1 M NaCl,
5% glycerol, 5 mM -mercaptoethanol, 0.1% PMSF). GST-
LIG3 (gi: 73747829) in complex with XRCC1 was obtained
by co-expression of 6His-tagged XRCC1 and GST-LIG3
from pGEX-4T with 250 M IPTG at 25◦C for 4 h and
purification by Ni-NTA, glutathione (GSTrap HP; 50 mM
Na-phosphate pH 7.5, 300 mM NaCl, 10 M ZnCl2, 10%
glycerol, 0.1% Tween-20, 2 mMDTT, 1% PMSF) and again
Ni-NTA affinity chromatography as for the XRCC1 purifi-
cation but supplementing all buffers with 10 M ZnCl2.
Highly pure fractions were dialysed against storage buffer
(10 mM Tris-HCl pH 8, 50 mM NaCl, 10% glycerol),
aliquoted and snap frozen.
Preparation of DNA substrates
Oligonucleotides containing the synthetic 3CAPS AP-sites
were synthesised as described previously (12). They were
purified by ion exchange HPLC (Dionex DNA Pac PA 200;
Thermo Fisher Scientific, Reinach, Switzerland), desalted
on SepPak columns (Waters Corporation, Milford, MA,
USA) and drop dialysed on Millipore MF-membrane fil-
ters. Quality of synthesised oligonucleotides was evaluated
by electrospray ionisation mass spectroscopy (ESI-MS).
All other oligonucleotides (PAGE-purified grade) were pur-
chased from Microsynth AG (Balgach, Switzerland) or
from Sigma-Aldrich (St. Louis, MO, USA). To prepare
double-stranded DNA substrates (5–25 M), complemen-
tary oligonucleotides were diluted in 10mMTris-HCl pH 8,
50 mM NaCl, denatured by heating at 95◦C for 2 min and
hybridised by slowly cooling down to 25◦C (1◦C/min).
For electrophoretic mobility shift assay (EMSA),
incision and reconstituted BER assays, 5′-fluorescein-
labelled 5′-FAM-d(CTAGGTTTGA GGTXGACATC
GGATCCATGG) and unlabelled 5′-d(CCTCGAGGTA
CCATGGATCC GATGTCGACC TCAAACCTAG
ACGAATTCCG) oligonucleotides were annealed (X rep-
resents either a 3CAPS, tetrahydrofuran or deoxyuridine)
to produce 3CAPS, THF and G•U mismatched heterodu-
plex substrates. The latter was subsequently enzymatically
converted to a AP-site by processing with UDG (0.05
U/pmol substrate) according to the manufacturer’s pro-
tocol. To ensure comparable conditions, also the 3CAPS
and THF substrates were incubated with UDG as above
and all reactions were stopped by adding uracil glycosylase
inhibitor UGI (NEB). The efficiency of AP-site generation
was routinely controlled by heating an aliquot at 99◦C
for 10 min under alkaline conditions (0.1 N NaOH).
Unlabelled competitor DNA heteroduplex substrates
for EMSA with TDG were prepared as described above
by annealing 5′-d(GGTTTGAGGT UGACATCGGA
TCC) and 5′-d(GGATCCGATG TCGACCTCAA ACC)
oligonucleotides.
The 5-hoU substrate was generated by annealing the
5′-fluorescein-labelled 5′-FAM-d(CGGAATTCGTCTAG-
GTTTGA GGT-5-hoU-GACATC GGATCCATGG
TACCTCGAGG GCAATGTCTA) and complementary
oligonucleotides d(TAGACATTGC CCTCGAGGTA
CCATGGATCC GATGTCGACC TCAAACCTAG AC-
GAATTCCG). To test Pol lyase activity, oligonucleotides
were either 3′-labelled with TexasRed using the ‘3′ EndTag
DNA labelling system’ (Vector Laboratories, Burlingame,
CA, USA) or synthesised with a 3′-Cy5.
Assessment of chemical stability of AP-sites
Natural AP-sites were prepared as described above and pu-
rified by chloroform extraction; simultaneously, 3CAPS-
containing and G•U mismatched substrates were made
without enzymatic digestion. Substrate DNA (100 nM) was
incubated in 50 mM Tris-HCl pH 8, 50 mM NaCl, 10 mM
MgCl2, 0.5 mMEDTAwith or without 130 g/ml BSA for
the indicated times. Reactions were stopped by the addition
of equal volumes of 100 mM Tris-HCl pH 8, 1% SDS, 200
mM NaBH4.
Electrophoretic mobility shift assay (EMSA)
DNA–TDG interactions were analysed in binding buffer
containing 50 mM Tris-HCl pH 8, 1 mM EDTA, 1 mM
DTT, 5% glycerol. Supplemented with 1 Munlabelled ho-
moduplex DNA [5′-d(TCGAGGTTCT GTTCCAGGGT
CCAGGTGGCG GA) and 5′-d(AGCTTCCGCC AC-
CTGGACCC TGGAACAGAA CC)] to block unspecific
DNA–protein interaction, 0.1 M labelled substrate DNA
was incubated with the indicated amounts of recombinant
human TDG at 37◦C for 15 min. For specific competition
experiments, TDG and the labelled substrate DNA were
incubated at 37◦C for 10 min prior to the addition of the
indicated amount of unlabelled competitor substrate and
then incubated for another 10min. Samples were then sepa-
rated by native PAGE (6% PAA, 19:1) in 0.5x TBE (45 mM
Tris-HCl, 45 mM boric acid, 1 mM EDTA) buffer (pre-run
and pre-warmed to 37◦C) at ∼10 V/cm for 45 min and the
protein–DNA complexes were monitored by gel scanning.
APE1 binding to DNA substrates was assessed by incu-
bation of the indicated amounts of APE1 with 25 nMDNA
substrate in 10 l of reaction buffer (50 mM Tris-HCl pH
8.4, 1 mM EDTA, 2 mM DTT, 5% glycerol, 200 g/ml
 at U
niversitÃ¤t Bern Volkswirtschftliches Institut on February 3, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
4 Nucleic Acids Research, 2015
BSA, 10 g/ml salmon sperm DNA) at 4◦C for 15 min.
Samples were then separated by native PAGE (5% PAA,
19:1) in 0.5x TAE (20 mM Tris-HCl pH 8, 10 mM acetic
acid, 0.5 mMEDTA) buffer at 4◦C at ∼7 V/cm for 150 min
and protein–DNA complexes were monitored by gel scan-
ning.
Binding of the indicated amounts of NEIL1 to 200 fmol
(20 nM) DNA substrates was assessed in 10 l of reaction
buffer (50 mM Tris-HCl pH 8, 1 mM EDTA, 2 mM DTT,
5% glycerol, 100 g/ml BSA) supplemented with 10 g/ml
salmon sperm and 1 M unlabelled homoduplex DNA at
25◦C for 15 min. Samples were then separated by native
PAGE (6% PAA, 19:1) in 0.5x TAE buffer at 4◦C at ∼10
V/cm for 80 min and protein–DNA complexes were moni-
tored by gel scanning.
In vitro DNA processing and repair assays
APE1 and FPG catalysed DNA incision was assessed in
10 mM Tris-HCl pH 8, 70 mM KCl, 7.5 mM MgCl2, 2
mMDTT supplemented with 100 g/ml BSA. Incision as-
says with the bifunctional DNA glycosylases hNTH1 and
hNEIL1 were performed in the same buffer but without
MgCl2. If not stated otherwise, reactions were done in 10
l volumes containing 0.5 pmol (50 nM) DNA substrate
and indicated amounts of recombinant protein at 37◦C for
10 (APE1) or 30 (DNA glycosylases) min.
In vitro reconstitution of BER with recombinant human
proteins and assessment of Pol lyase activity were per-
formed in 20 l reactions with 40 mM HEPES-KOH pH
8, 70 mM KCl, 7 mM MgCl2, 1 mM DTT and 500 g/ml
BSA. Natural AP-site substrate was generated from a G•U
heteroduplex by UDG, which was equally applied to all
other substrates. If not stated otherwise, BER reconstitu-
tions contained 2 pmol substrate DNA (100 nM), 2 mM
ATP and 50 M of each dNTPs. 1 pmol of each BER en-
zymes (50 nM) was added to the reaction stepwise, each in-
cubated at 37◦C for 10 min. Nicked substrates for the as-
sessment of Pol lyase activity were prepared by incubating
1 pmol (50 nM)AP-site-containing substrates with 200 fmol
APE1 (10 nM) at 37◦C for 10min. 1 pmol Pol (50 nM) was
then added and incubated at 37◦C for 20 min. Nicked sub-
strates for Pol strand extension/displacement were either
generated by APE1 as described above or by co-incubation
of UDG and Endo IV in NEB3 buffer for 1 h. A total of 0.5
pmol of substrate DNA (50 nM) and the indicated amount
of Pol, supplemented with additional recombinant BER
proteins and dNTPs (50 M each) as specified, were incu-
bated in 10 l of the above reaction buffer at 37◦C for 10
min.
Reactions were stopped by the addition of an equal vol-
ume of 100 mM Tris-HCl pH 8, 1% SDS and 200 mM
NaBH4 to stabilise unprocessed natural AP-sites. Following
incubation on ice for 15 min and ethanol-precipitation o/n,
samples were resuspended in 10 l 1x TBE/90% formalde-
hyde and denatured at 99◦C for 5 min. Reaction prod-
ucts were then analysed on denaturing 20% PAGE (PAA
(19:1)/8M urea/1x TBE), pre-run at 30 V/cm for 10 min in
1x TBE running buffer pre-heated to 50◦C. Samples were
loaded and run at 30 V/cm for 5 min and then at 16 V/cm
for 45min. To analyse 5′-dRP lyase activity of Pol, samples
were separated by 15% PAGE (PAA (19:1)/8 M urea/1x
TBE) using a 16-cm gel system (SE 400, GE Healthcare)
running at 20 mA/600 V for 100 min.
Cleavage inhibition and reductive crosslinking assays
Cleavage inhibition of hNEIL1 was assessed in 10mMTris-
HCl pH 8, 70 mMKCl, 2 mMDTT and 100 g/ml BSA in
a reaction volume of 10 l. A total of 0.75 pmol of recom-
binant hNEIL1 (75 nM) was pre-incubated with increasing
amounts (0, 0.25, 0.5, 1 pmol) of 5′-FAM-labelled competi-
tor substrate containing either authentic AP-site, 3CAPS or
THF (unlabelled homoduplex DNA as described for TDG-
EMSA was included to add up to 1 pmol total DNA sub-
strate) at 37◦C for 10 min. Samples were then transferred to
ice to add 0.5 pmol of the 5′-FAM-labelled 5-hoU substrate
and then further incubated at 37◦C for 30 min. Reactions
were stopped by sodium borohydride (NaBH4)-containing
buffer and DNA precipitated as described above. Samples
were separated by 15% PAGE (PAA(19:1)/8 M urea/1x
TBE) running at 30 V/cm for 5 min and then at 16 V/cm
for 45 min.
Reductive crosslinking was performed in reaction vol-
umes of 20 l using the above described buffer conditions
supplemented with 50 mM NaBH4 at 37◦C for 30 min.
1 pmol of 5′-FAM-labelled AP-site, 3CAPS or THF sub-
strate was mixed with increasing amounts of the bifunc-
tional DNA glycosylase in 14 l reaction volume on ice.
Three times 2 l of 166 mM NaBH4 in reaction buffer was
added in 10 min intervals from reaction start. Reactions
were stopped by adding Laemmli sample buffer (45 mM
Tris-HCl pH 6.8, 10% glycerol, 1% SDS, 0.1% bromophenol
blue, 50 mMDTT) and heating at 99◦C for 5 min. Samples
were separated by 15% SDS-PAGE, supplemented with 2
M urea at 15 mA for 45 min.
Gel quantification and statistics
Gels with 5′-FAM- and/or 3′-Cy5/TexasRed-labelled sub-
strates were scanned on ‘Typhoon 9400’ laser scanner (GE
Healthcare Life Sciences) using 488 nm blue or 633 nm red
laser, respectively, and bands were quantified by the ‘Image-
Quant’ software package.
Statistical analyses of data were done by two-sided Stu-
dent’s t-test in MS Excel 2013. Due to the product inhibi-
tion of APE1 on AP-site substrates, enzyme kinetic param-
eters for this enzyme were calculated as apparent kcat values
by the linear curve fitting algorithm in the linear range of
time-course experiments rather than by Michaelis-Menten
kinetics.
RESULTS
3CAPS – a chemically stable structural analogue of the nat-
ural abasic sites
Because of the hemiacetal function at the anomeric centre,
naturally occurring AP-sites are chemically reactive. They
are prone to β- and δ-elimination and thereby cause DNA
strand breaks. The average life-time of an AP-site was esti-
mated to be about 8 days, applying the plasmid relaxation
assay under physiological buffer condition at 37◦C (14).
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We compared the stability of a natural AP-site with that
of the structural and functional AP-site analogue 3CAPS
both located at identical positions opposite a G within a
labelled synthetic DNA duplex (Figure 1A). In our stan-
dard reaction buffer containing BSA, the time-dependent
decay of the AP-site gave rise to three DNA products with
distinct migration properties (Figure 1B), most likely repre-
senting β- and/or δ-eliminations and spontaneous hydrol-
ysis. About 50% and 80% of the AP-site substrate had de-
composed after 6 and 12 days of incubation, respectively
(Figure 1C) and this was not due to contaminating activity
of the BSA added to the buffer (Supplementary Figure S1).
We estimated the half-life of the enzymatically produced
natural AP-site in our DNA substrates to be around 6 to 7
days, consistent with the AP-site degradation rate measured
previously (14). Notably, these in vitro measurements with
purified DNA may underestimate AP-site degradation in
living cells as spontaneous strand breakage at AP-sites ap-
pears to occur more frequently in nucleosomal DNA (15).
By contrast, no comparable decay of 3CAPS-containing
andG•Umispaired substrates was detectable over the same
period of time (Figure 1B and C). We therefore conclude
that 3CAPS is an AP-site analogue with substantially in-
creased chemically stability.
The 3CAPS AP-site is processed by human APE1
In mammals, APE1 is the main endonuclease activity act-
ing on DNA AP-sites. We investigated the ability of hu-
man APE1 to process a 3CAPS AP-site in double-stranded
DNA, using an enzymatically produced natural AP-site in
the same sequence context as a reference. As expected from
previous observations (16,17,18), APE1 cleaved the natural
AP-site with very high efficiency; a 100-fold molar excess
of AP-site substrate was processed to near completion in
about 5 min (4 fmol APE1; Figure 2A and B). By compar-
ison, the THF substrate was processed with only slightly
lower efficiency, whereas 3CAPS cleavage was significantly
reduced (Figure 2A and B). Notably, even when present in
a molar excess (up to 5-fold) over substrate, APE1 was not
able to cleave more than about 50% of the 3CAPS substrate
(Figure 2B). Similarly, 3CAPS substrate was found to be
less efficiently processed by the bacterial Endonuclease IV,
reaching a plateau of about 70% of cleaved substrate (Sup-
plementary Figure S2). Yet, the differences in processing
the authentic AP-site and its structural analogues appeared
to be less prominent for the Endonuclease IV than for its
mammalian functional homologue APE1. As the chemical
structure of 3CAPS does not predict a significant effect of
the modification on the hydrolysis of its 5′-phophodiester
bond, we tried to pinpoint the reason for APE1’s ineffi-
ciency on this substrate. Assessing the kinetic parameters
for substrate processing by APE1 on the basis of product
formation over time in a reaction with a 2000-fold excess
of substrate over enzyme (0.25 fmol APE1) (Figure 2C), we
calculated an apparent kcat for natural AP-site processing of
∼2.5 substrates per second, which is in the range of previous
calculations (18,19,20,21). By contrast, the apparent kcat re-
sulting for the THF and 3CAPS AP-site substrates were 2.5
and 25 times lower, respectively. Thus, although it does not
alter the configuration of the 5′-phosphodiester, the 3CAPS
Figure 2. The synthetic abasic site analogue 3CAPS is processed by the
major human AP-endonuclease APE1. (A) 0.5 pmol of substrate DNA
containing enzymatically produced natural AP-sites (AP) or the synthetic
analogues 3CAPS and THF were processed by increasing amounts of re-
combinant APE1 for 5min and analysed by denaturing gel electrophoresis.
(B) Quantitative analysis of AP-site processing with increasing amounts of
APE1. (C) For the kinetic analysis of AP-site processing, substrate DNA
was incubated with 0.25 fmol recombinant APE1 for the time indicated.
Apparent kcat values were calculated by the curve fitting in the linear range
(dotted lines). Error bars, SEM of three experiments.
modification significantly affects the rate of APE1 hydroly-
sis.
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3CAPS affects APE1 binding but has characteristics of an
authentic AP-site
The observation that processing of the 3CAPS substrate by
APE1 was inefficient and required high enzyme concentra-
tions (Figure 2) suggested substrate affinity to be the rate
limiting factor in these reactions.We therefore assessed sub-
strate binding byAPE1 in EMSA.Robust substrate binding
in this assay required approximately 10-fold molar excess
of APE1 over substrate. With the natural AP-site, this ex-
cess yielded about 10% detectable enzyme–substrate com-
plex (Figure 3A). The same level of binding of the THF
substrate required a 1.2–1.5-fold higher concentration of
APE1; whereas no detectable bindingwas observedwith the
3CAPS-containing substrates and 10-fold excess of APE1.
These data establish that the synthetic 3CAPS AP-site can
be processed but is hardly recognized by the major cellu-
lar AP-endonuclease. The reduced affinity of APE1 for the
3CAPS can be rationalised on the basis of a crystal struc-
ture of the APE1–DNA complex (22). The replacement of
the 3′-oxygen by a CH2 group, as in 3CAPS, may abolish
weak long range contacts, disrupting the structural water
network (Supplementary Figure S3).
To address whether the effect of the 3CAPS modification
on protein interaction is specific for APE1, as implicated by
the structural data, or a rather general feature of its chem-
istry, we examined binding by the monofunctional DNA
glycosylase TDG, showing a high affinity for and rigid bind-
ing to natural AP-sites (23,24). Incubation of TDG with
natural AP-site-, THF- or 3CAPS-containing substrates
gave rise to discrete, slower migrating bands in EMSA, in-
dicating the formation of defined protein–DNA complexes
(Figure 3B). In contrast to APE1, TDG bound all three
AP-site variants with comparable efficiency. We then chal-
lenged the binding of TDG to the natural AP-site and the
3CAPS analogue by competition with G•U mismatched
heteroduplex substrates. Once bound, TDG hardly dissoci-
ated from either the 3CAPS or the AP-sites substrates, even
when a 10-fold molar excess of unlabelled competitor sub-
strate was provided, indicating a strong affinity of TDG to
these AP-sites (Figure 3C). These results demonstrate that
TDG binds the 3CAPS substrate as efficiently as a natu-
ral AP-site, supporting the notion that 3CAPS represents a
structurally authentic and biologically active AP-site ana-
logue although the modification affects APE1 interaction.
The 3CAPS AP-site is recognised but not processed by bi-
functional DNA glycosylases
Unlike TDG, the human bifunctional DNA glycosylases
hNTH1 and hNEIL1 not only excise the substrate base
from the DNA but also incise the resulting AP-sites by
their intrinsic lyase activity (13,25,26,27,28,29,30). Whereas
hNTH1 catalyses β-elimination only, generating a nick with
3′-dRP and 5′-phosphate ends, hNEIL1 processes consec-
utive β- and δ-elimination steps to produce a single nu-
cleotide gap with flanking 3′- and 5′-phosphate termini. We
compared substrates with a natural AP-site, a 3CAPS or a
THF for DNA strand incision by these DNA glycosylases.
A 4-fold molar excess of enzyme over substrate cleaved 90–
95% of natural AP-sites under the reaction conditions ap-
plied (30 min, 37◦C) (Figure 4A and B). As expected, the
hNTH1 reaction products migrated slower than those pro-
duced by APE1, indicating the presence of a 3′-dRP instead
of the 3′-OH (Figure 4A). By contrast, the major product of
hNEIL1 as well as its bacterial orthologue FPGmigrated at
the position of the chemically induced δ-elimination prod-
uct (C+), bearing a 3′-phosphate group. Applying the same
experimental condition to the substrates with the 3CAPS
and THF analogues, we could not detect any strand inci-
sion (Figure 4A and B) by either of the DNA glycosylases,
indicating that neither β- nor δ-elimination was possible on
these substrates.
Although strand incision by bifunctional DNA glyco-
sylases was blocked by both the 3CAPS and the THF
AP-sites, the underlying reasons are likely to be differ-
ent. Whereas THF has no hemiacetal functionality and
thus cannot form the transient Schiff base intermediate
established between bifunctional DNA glycosylases and
their substrates, this should still be possible with the
3CAPS substrate. To test this, we analysed the potential
of hNEIL1, hNTH1 and FPG to form covalent interme-
diates with the AP-site substrates by reductive crosslink-
ing, which was shown to trap the Schiff base intermedi-
ates (13,30,31,32,33,34). We thus incubated the substrate
DNAs containing either a 3CAPS, a THF, or a natural AP-
site with hNEIL1 (Figure 4C), hNTH1 or bacterial FPG
(Supplementary Figure S4) in the presence of NaBH4 and
analysed the formation of protein–DNA crosslinks on de-
naturing protein gels. 3CAPS as well as natural AP-site
substrates yielded slow-migrating covalent protein–DNA
complexes with all three bifunctional DNA glycosylases in
a concentration- and borohydride-dependent manner; the
THF substrate did not, as expected. We thus conclude that,
unlike the THF substrate, the 3CAPS AP-site is able to
form a transient Schiff base intermediate with bifunctional
DNA glycosylases, owing to the presence of the hemiacetal
functionality. Notably though, the final β-elimination step
is blocked and the strand incision cannot take place.
The 3CAPS AP-site inhibits bifunctional DNA glycosylases
Our results indicated that 3CAPS AP-sites might inhibit
bifunctional DNA glycosylases by trapping them in the
Schiff base complex. To test this, we assessed the combined
glycosylase/AP lyase activity of hNEIL1 on a substrate
containing 5-hydroxy uridine (5-hoU) (Figure 5A). We pre-
incubated hNEIL1 with increasing amounts of substrate
containing either a natural, a 3CAPS or a THFAP-site or a
G•Umismatch and then assayed strand incision activity on
the 5-hoU substrate (Figure 5B). Whereas the presence of
G•Uheteroduplex DNA had no inhibitory effect on 5-hoU
processing by hNEIL1, the natural AP-site, a physiological
substrate for the glycosylases, competed in a roughly stoi-
chiometric manner (Figure 5C). THF-containing competi-
tor, which is bound but not processed by hNEIL1, reduced
5-hoU processing more significantly. The 3CAPS competi-
tor DNA, however, showed the most striking effect, inhibit-
ing more than 90% of hNEIL1 activity at only a 2-fold mo-
lar excess over the 5-hoU substrate. A similar inhibitory ef-
fect of the 3CAPS competitor was observed when assess-
ing the base excision efficiencies (alkaline AP-site cleavage)
of hNEIL1 on 5-hoU (Supplementary Figure S5A and B)
 at U
niversitÃ¤t Bern Volkswirtschftliches Institut on February 3, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 7
Figure 3. The structural integrity of the synthetic AP-site analogue 3CAPS. DNA substrates containing either G•U mismatches (MM), enzymatically
produced AP-sites (AP) or the synthetic analogues 3CAPS and THF were incubated with increasing amounts of APE1 or TDG. The formation of DNA–
protein complexes was analysed by EMSA. (A) Binding of APE1 to 250 fmol of substrate DNAwas quantitatively analysed. (B) Binding of TDG to 1 pmol
of labelled DNA substrate was quantitatively analysed in the presence of non-labelled homoduplex DNA to block unspecific binding. (C) For competition
experiments, 1 pmol of 3CAPS or natural AP-site substrate was incubated with 4 pmol of TDG prior to the addition of the indicated amounts of G•U
competitor heteroduplex DNA. Error bars, SEM of the indicated number of experiments.
and of its bacterial homologue FPG on 8-oxo-G substrates
(Supplementary Figure S5C). For FPG acting on 8-oxo-G,
we calculated a competitive inhibition IC50 value of about
1.0 nM (Supplementary Figure S5C) and a dissociation
constant Ki of 0.6 nM for the 3CAPS substrate, which is in
the range reported for other AP-site analogues (8,35). No-
tably though, the affinity of FPG for 3CAPS is higher than
that for THF (2.6 nM versus 25 nM), whichmay explain the
stronger inhibitory effect of 3CAPS AP-sites. Indeed, as-
sessing the affinity of hNEIL1 with the AP-sites by EMSA
revealed that 3CAPS is bound more strongly than natural
AP-sites, whereas THF exhibited only a marginally higher
affinity than a mismatched control DNA (Figure 5D). Our
data thus suggest that 3CAPSAP-sites bearing a functional
hemiacetal group inhibit bifunctional DNA glycosylases by
high affinity interaction and blocking the β-elimination step
following the formation of the covalent enzyme–DNA in-
termediate.
DNA Pol can extend the 3′- but not process the 5′-terminus
of cleaved 3CAPS substrate
The N-terminal domain of Pol possesses an intrinsic β-
lyase activity (36), which plays a pivotal role in canonical
short-patch BER (3,4,6). In this pathway, APE1-mediated
AP-site incision generates single-stranded DNA breaks
with a 5′-deoxyribose-phosphatemoiety at one end and a 3′-
hydroxyl group at the other. In non-replicating cells, mainly
Pol then adds the missing nucleotide to the 3′-OH and
removes the 5′-dRP via β-elimination, hence generating a
substrate for ligation by the DNA Ligase I (Lig1) or by the
XRCC1/Lig3 complex. Using recombinant proteins, we re-
constituted this BER pathway in vitro and assayed the in-
dividual reaction steps with our AP-site substrates (Figure
6A).When providing dCTP only, the incision products gen-
erated by APE1 on the natural AP-site were extended by
Pol and efficiently ligated by the XRCC1/Lig3 complex,
indicating that the 5′-dRPwas efficiently processed by Pol.
By contrast, ligation products were detectable neither with
the 3CAPS nor with the THF substrates, even though Pol
extended the APE1-cleaved intermediates (Figure 6B). Us-
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Figure 4. The synthetic AP-site analogue 3CAPS is recognised but not processed by bifunctional DNA glycosylases. (A) Strand incision of 0.5 pmol of the
natural AP-site (AP) and the analogues 3CAPS and THF by the human bifunctional DNA glycosylases hNTH1 (2 pmol) and hNEIL1 (2 pmol) as well as
the bacterial FPG (0.4 U) was assessed in comparison with APE1 (100 fmol). (B) Quantification of AP-site substrate processing. Error bars, SEM of three
experiments. (C) Functional interaction between human NEIL1 and AP-site substrates was assessed by reductive crosslinking with sodium borohydride
(NaBH4). 1 pmol substrate DNA was incubated with increasing amounts of NEIL1 for 30 min at 37◦C in standard reaction buffer supplemented with 50
mM NaBH4. Samples were separated by SDS-PAGE and the formation of covalently linked protein–DNA complexes was detected.
Figure 5. 3CAPS-containing substrates inhibit the enzymatic activity of NEIL1. (A) Scheme of the DNA substrates with a 5′-fluorescein label (F) used in
the competitive inhibition experiment of 5-hoU processing by human NEIL1. (B) Increasing amount of DNA containing enzymatically generated natural
AP-sites (AP), the analogues 3CAPS and THF or G•U (MM) was pre-incubated with 0.75 pmol hNEIL1 for 10 min. After addition of 0.5 pmol of 5-hoU
DNA substrate and co-incubation for 30 min, the glycosylase/AP lyase activity of hNEIL1 in the presence of the competitor DNAwas assessed. Reactions
without hNEIL1 served as negative controls. (C) The percentage of processed 5-hoU substrates relative to controls without competitor was statistically
analysed by Student’s t-test comparing them to the natural or THF AP-site (black or grey asterisks, respectively. *p< 0.05; **p< 0.01, ***p< 0.001). The
dotted line indicates the background cleavage signal obtained from the negative control. (D) A total of 200 fmol of substrate DNA was incubated with
increasing amounts of human NEIL1 at 25◦C for 15 min. The formation of DNA–protein complexes was assessed by EMSA and quantitatively analysed.
Error bars, SEM of three experimental replicas.
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Figure 6. Inhibition of short-patch BER by 3CAPS. (A) DNA substrates with a green 5′ (F) or red 3′ (R) fluorescent label used for BER reconstitution
(B), Pol lyase activity (C) and strand extension/displacement (D,E) experiments. (B) Enzymatic steps of BER were assessed in the presence of dCTP or
dNTPs. In intervals of 10 min, 2 pmol of 5′-labelled substrate containing the natural AP-site (AP) or the synthetic 3CAPS and THF were incised with 200
fmol APE1, extended with 1 pmol of Pol and ligated with 1 pmol of XRCC1/Lig3 complex. The rightmost lanes (grey plus signs) show the co-incubation
of all BER components for 30 min. (C) Analysis of 5′-dRP lyase activity of Pol on APE1-incised natural and 3CAPS AP-sites. 0.5 pmol of 3′-labelled
substrate were incised with 100 fmol of APE1 for 10 min before incubating with 0.5 pmol of Pol for 20 min. Natural AP-sites were incubated with
hNTH1 for 30 min or βδ-eliminated (C+) by heating under alkaline conditions to generate migration controls for 5′-phosphate (5′-P) oligonucleotides.
The asterisks indicates an undefined fragment of the natural AP-site substrate. (D) Increasing amounts of Pol (0–64 fmol) were used to analyse strand
extension and displacement during repair DNA synthesis. A total of 0.5 pmol of AP-site, 3CAPS and THF substrates were incised by digestion with
bacterial endonuclease IV (Endo IV). In the presence of 250 fmol XRCC1/Lig3 complex and dCTP/dGTP (50 M each), DNA synthesis was induced by
addition of the indicated amount of Pol. After 10 min of incubation at 37◦C, reactions were stopped and analysed. Chemically induced βδ-elimination
of AP-sites (C+) were used as migration standard (13 nt oligonucleotide with 3′-phosphate). Arrow heads mark shorter incised substrate oligonucleotides
(<13 nt), not considered in the quantification. Shown are image sections covering the 12–20 nucleotide range; full gel scans can be found in Supplementary
Figure S6A. (D) Quantitation of Pol strand extension/displacement activity, showing the relative abundance of incised substrate (13 nt) and extended
strands by 1 and 2 nucleotides (+1, +2, respectively). Error bars, SEM of three experiments.
ing 3′-labelled substrates, we found that the 5′-termini of
APE1-incissed 3CAPS substrates but not the natural AP-
site substrates were resistant to processing by the dRP lyase
activity of Pol (Figure 6C).
Repair intermediates with blocked 5′-ends for the 5′-dRP
lyase activity of Pol require processing by alternative path-
ways such as long-patch BER, which involves, in addition
to Pol and XRCC1/Lig3, replicative DNA polymerases
and ligase. DNA polymerase  (Pol) but also less pro-
cessive polymerases such as Pol are able to displace the
strand with the 5′-dRP end (37,38), hence producing a 5′-
flap structure that can then be processed by an endonucle-
ase to generate an appropriate end for ligation. To reca-
pitulate this scenario in vitro, we allowed Pol to extend
past the 5′-dRP or the 5′-3CAPS by adding all four nu-
cleotide triphosphates (Figure 6B). Nearly all cleaved AP-
sites became elongated and a substantial part of them were
longer than 30 nucleotides, indicating a complete synthesis-
dependent displacement of the DNA strand and extension
to the end of the 10 nucleotide longer template strand by
Pol. Notably, the strand displacement activity and proces-
sivity of Pol appeared to be stimulated by the presence of
the non-cleavable 5′-termini generated by 3CAPS and THF
incision. This observation was substantiated when DNA
synthesis and strand displacement by Polwere assayed un-
der near single turnover conditions, allowing for extension
by two nucleotides by providing only dCTPs and dGTPs
(Figure 6D). While incised natural AP-sites were predom-
inantly extended by one nucleotide, a majority of 3CAPS
and THF repair intermediates were readily extended by
two nucleotides, indicating an increased strand displace-
ment activity. For authentic AP-sites, an about 4-fold higher
Pol concentration was required to reach comparable lev-
els (Figure 6E). The enhanced strand displacement by Pol
could be promoted by a destabilisation of the base-pairing
at the non-removable CAPS and THF ends and was found
to be largely independent of XRCC1 (Supplementary Fig-
ure S6B). From these results, we conclude that 3CAPS-
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containing substrates cannot be processed by canonical
short-patch BER because of the failure of end trimming by
Pol and, hence, generate a necessity for strand displace-
ment and long-patch BER.
DISCUSSION
Abasic sites (AP-sites) represent abundant DNA lesions in
cells, bearing a high mutagenic and cytotoxic potential due
to the missing coding information and blockage of DNA
replication and transcription (2,3). Investigation of AP-site
repair has been hampered by their chemical reactivity due
to hemiacetal functionality at the anomeric centre, which
promotes spontaneous nicking of the DNA by β- and δ-
elimination. For this reason, research has made use of AP-
site analogues missing this functionality at the anomeric
centre. To provide a more authentic alternative, Mosimann
et al. (12) introduced 3CAPS, an AP-site analogue replac-
ing the 3′-oxygen with a methylene to prevent β-elimination
while preserving the structure and the anomeric centre of
the natural AP-site.
Assessing the efficiency of APE1 to interact with and pro-
cess authentic AP-sites and its analogues, we observed a re-
duced activity on a THF substrate (Figures 2A and 3A),
which is in line with previous observations (11,18,39,40,41),
and a comparably poor processing of the 3CAPS substrate.
The 3CAPS incisions formed, however, were extendable by
DNApolymerase , indicating that APE1 generated proper
3′-OH termini (Figure 6B). Given the structural authentic-
ity of the 3CAPS substrate, as implicated by the efficient
and specific binding of the AP-site-interacting DNA glyco-
sylases TDG andNEIL1 (Figures 3B and 5D), its poor pro-
cessing by APE1 (kcat 0.1/s) (Figure 2) and inability to in-
teract with APE1 in an EMSA (Figure 3A) was unexpected.
The reduced affinity and activity compared to THF sug-
gested that the 3′-oxygen of an AP-site plays a more im-
portant role for recognition and processing by APE1 than
the conserved hemiacetal group. This is indeed supported
by crystallographic evidence, indicating that the 3′-oxygen
of the AP-site is engaged in two long range contacts to Asn-
229 of APE1 and to a water molecule involved in a struc-
tural water network (Supplementary Figure S3) (22). No-
tably, the efficiency of 3CAPS processing by the structurally
and catalytically distinct bacterial AP-endonuclease Endo
IV (42) was also reduced, though to a lesser extent (Supple-
mentary Figure S2), indicating a general importance of the
3′-oxygen of AP-sites in AP-endonuclease function.
With its preserved hemiacetal functionality, the 3CAPS
AP-site provides a suitable tool for biological, biochemical
and structural studies of DNA repair. Our data show that
3CAPS-containing substrates will be suited to (i) separate
short- from long-patch BER in in vitro as well as in in cell
repair assays, (ii) identify and functionally characterise AP-
site-interacting protein and (iii) inhibit bifunctional DNA
glycosylases.
Whether and howa givenBER intermediate is channelled
into the short- or long-patch pathway is not yet fully under-
stood (2,6,43). In canonical short-patch BER, the 5′-dRP
moiety generated by APE1 is removed by the 5’-dRP/AP
lyase activity of Pol, involving a β-elimination mechanism
(44,45), which is essential to provide suitable DNA ends for
ligation. In BER assays with both the THF and 3CAPS
AP-sites, the ligation step was fully blocked (Figure 6B).
This was due to the inability of Pol to perform the β-
elimination of the THF and 3CAPS residues from the 5′
end (Figure 6C). On such intermediates, productive repair
can only occur through strand displacement followed by
cleavage of the resulting 5′-flap structure and ligation. Al-
though both, THF and 3CAPS would equally block short-
patch BER at this step, only 3CAPS is able to functionally
engage by Schiff base formation with bifunctional DNA
glycosylases (Figure 4C and Supplementary Figure S4) or
Pol and, hence, to recapitulate an authentic BER context.
In this regard, 3CAPS may provide a significant advan-
tage to study pathway choice at the biochemical and cel-
lular level. For instance, our data provide some insight into
the coordination of 5′-dRP elimination and DNA synthesis
steps during BER. While the 3CAPS AP-site effectively in-
hibited the dRP lyase activity of Pol, it rather stimulated
the DNA polymerase and/or strand displacement activi-
ties (Figure 6D and E), suggesting that 5′-dRP removal by
Pol is uncoupled from DNA synthesis. A potential appli-
cation exploiting the aldehyde functionality in the 3CAPS
substrates is the identification of proteins interacting with
and processing AP-sites in cellular extracts as done previ-
ously with the authentic AP-site resulting in the identifi-
cation of the lyase activities of Ku and PARP1 (46,47,48).
As documented here for hNEIL1, hNTH1 and FPG, the
Schiff base intermediate, covalent linking the AP-site with
the enzyme, is readily formed with the 3CAPS substrate
(Figure 4C and Supplementary Figure S4) but the final β-
elimination step is blocked (Figure 4A), stabilising the in-
termediate DNA–substrate complex (Figure 5D). Consid-
ering the altered affinities, 3CAPS provides the opportunity
to trap and identify distinct subsets of AP-site-interacting
proteins in borohydride crosslinking experiments. Further-
more, the chemical stability of the 3CAPS (Figure 1, 12)
in combination with the structural authenticity and higher
affinities to bifunctional DNA glycosylases may facilitate
the co-crystallisation of such protein–DNA complexes for
structural and mechanistic investigations. In particular, it
will help decipher the role of the hemiacetal group in these
interactions, which has been neglected so far as most stud-
ies were done with the THF analogue. Finally, our results
show that 3CAPS is a potent inhibitor of the DNA gly-
cosylases NEIL1 and FPG (Figure 5 and Supplementary
Figure S5). The competitive inhibition of these bifunctional
DNA glycosylases results from their functional but non-
productive interaction with the 3CAPS AP-site, which was
significantly stronger than interactions with THF. These
features of 3CAPS can be exploited for mechanistic stud-
ies with recombinant BER proteins or cell extracts.
In conclusion, we evaluated the characteristics of a con-
ceptually novel AP-site analogue with respect to its suit-
ability for the biochemical and structural investigation of
BER as well as for application as DNA repair inhibitor.
In contrast to other chemically stable AP-site analogues,
3CAPS maintains the aldehyde functionality, which allows
for screening of enzymes that would interact and process
such a DNA lesion. In addition, the retained aldehyde
functionality makes the 3CAPS a competitive inhibitor of
BER, affecting mainly proteins with AP lyase activities. Fi-
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nally, because canonical short-patch BER is not possible
in 3CAPS-containing substrate, it could be used as tool to
study pathway choice or long-patch BER in vitro as well as
in vivo.
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